# Nofima

肽生物活性研究 — 中试线与糖尿病肽临床试验.

Source: https://cn.bioecon.ru/companies/nofima/
Updated: 2026-06-28

- 国家: Norway

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 融资 | 挪威研究理事会(The Research Council of Norway)(项目包括TailoTides、Pepfishing) | https://nofima.com/projects/pepfishing/, https://nofima.com/projects/sensor-guided-enzymatic-protein-hydrolysis-and-separation-technologies-for-tailored-biomanufacturing-of-bioactive-peptides/, https://nofima.com/results/tailored-peptides-a-key-to-better-health/ |
| 营收 | 7.36亿挪威克朗(NOK)(2024年) | https://nofima.com/, https://nofima.com/about/ |
| 员工人数 | 371名员工 | https://nofima.com/, https://nofima.com/about/ |
| 生产基地 | 挪威特罗姆瑟（Tromsø）（位于Nofima总部的Biotep工厂） | https://biotep.no/en/, https://biotep.no/om-biotep/, https://nofima.com/facility/biotep/ |
| 产能 | 可处理从小批量到1,000公斤的产量；具有灵活的微型工厂规模 | https://biotep.no/en/, https://biotep.no/ofte-stilte-sporsmal/ |
| 监管批准 | Biotep已获挪威食品安全局（Mattilsynet）批准 | https://biotep.no/en/, https://biotep.no/ofte-stilte-sporsmal/ |

独立来源: biotep.no

## 技术

- [海洋肽与营养保健品](https://cn.bioecon.ru/technology/marine-peptides-nutraceuticals/)